Verily planning $5M expansion of tech-based opioid treatment initiative

Alphabet’s life sciences arm Verily is seeking funding to expand its OneFifteen opioid addiction and recovery campus, launched earlier this year in partnership with Dayton, Ohio-based Premier Health and Kettering Health Network, the Dayton Daily News reports.

Advertisement

The project will reportedly cost a total of $5 million. It proposes the addition of a 5,000-square-foot outpatient detox center to the two existing OneFifteen outpatient clinics in Dayton. OneFifteen President and CEO Marti Taylor, MSN, told the Daily News the organization is primarily seeking state funding to support the project.

The completed OneFifteen campus, which is named for the daily average of opioid overdose deaths in the U.S. in 2017, will ultimately comprise six facilities, offering both outpatient and inpatient care, as well as emergency and mental health services and long-term detox support. Many of the offerings will have tech-based components, and data will be continually collected and analyzed across the campus to improve clinical, social and cost outcomes.

More articles on opioids:
Counterterrorism devices repurposed to test for fentanyl
Oklahoma judge corrects his math error, lowers J&J opioid payment by $107M
States ranked by rate of youth affected by the opioid crisis

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.